Rcn Pareto Strategic Allocation ETF (PRTO)
Rcn Pareto Strategic Allocation ETF (PRTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRTO | NEUP | QNTM | ||
| Company | Rcn Pareto Strategic Allocation ETF | Neuphoria Therapeutics Inc | Quantum Biopharma Ltd | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 25.50 | 4.15 | 5.08 | ||
| High | 25.50 | 4.50 | 6.21 | ||
| Low | 25.47 | 4.10 | 4.40 | ||
| Latest | 25.47 | 4.12 | 4.41 | ||
| Change | +0.19 | +0.05 | -0.42 | ||
| % Change | +0.73% | +1.23% | -8.70% | ||
| Volume | 500 | 69,000 | 1,158,000 | ||
| 20-Day Average Volume | N/A | 61,675 | 764,835 | ||
| Previous Close | 25.29 | 4.07 | 4.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | N/A | 4.44 | 3.32 | ||
| 20-Day Raw Stochastic | N/A | 27.18% | 53.18% | ||
| 20-Day Relative Strength | N/A | 44.52 | 52.75 | ||
| Weighted Alpha | N/A | -19.00 | -84.74 | ||
| Today's Opinion | N/A | 56% Sell | 56% Sell | ||
| Previous Opinion | N/A | 56% Sell | 56% Sell | ||
| Last Month's Opinion | N/A | 40% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.67% since 03/25/26 | -5.72% since 03/25/26 | +1.38% since 03/25/26 | ||
| Low | 24.68 on 03/30/26 | 3.84 on 03/30/26 | 3.51 on 03/27/26 | ||
| High | 25.50 on 04/01/26 | 4.50 on 04/01/26 | 6.47 on 03/30/26 | ||
| 1-Month | |||||
| %Chg | N/A since 03/25/26 | -0.72% since 02/27/26 | +24.23% since 02/27/26 | ||
| Low | 24.68 on 03/30/26 | 3.84 on 03/30/26 | 2.07 on 03/11/26 | ||
| High | 25.50 on 04/01/26 | 4.94 on 03/04/26 | 6.47 on 03/30/26 | ||
| 3-Month | |||||
| %Chg | N/A since 03/25/26 | +6.19% since 12/31/25 | -39.59% since 12/31/25 | ||
| Low | 24.68 on 03/30/26 | 3.80 on 01/02/26 | 2.07 on 03/11/26 | ||
| High | 25.50 on 04/01/26 | 4.94 on 03/04/26 | 7.65 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | N/A since 03/25/26 | -70.25% since 10/01/25 | -73.32% since 10/01/25 | ||
| Low | 24.68 on 03/30/26 | 3.64 on 12/29/25 | 2.07 on 03/11/26 | ||
| High | 25.50 on 04/01/26 | 21.40 on 10/07/25 | 19.30 on 10/02/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 18,524 | 21,941 | 18,436 | ||
| Shares Outstanding, K | 22,179 | 5,391 | 3,817 | ||
| Annual Sales | 0 | 15,650,000 | 0 | ||
| Annual Net Income | -20,730,000 | -370,000 | -26,180,000 | ||
| Last Quarter Sales | N/A | 0 | 0 | ||
| Last Quarter Net Income | N/A | 1,860,000 | -2,860,000 | ||
| 60-Month Beta | 0.60 | 0.50 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.77 on 02/17/26 | -0.71 on 03/26/26 | ||
| Latest Earnings Date | 03/11/20 | 05/19/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||